Market Overview

Markets are bouncing back after Wednesday’s selloff triggered by Fed Chair Warsh’s hawkish press conference. The US-Iran peace deal is providing a geopolitical tailwind, pushing oil lower and risk assets higher. S&P futures are up ~1%, Nasdaq futures up ~2.2%, with semiconductors and clean energy leading the recovery as the “higher for longer” narrative gets partially offset by reduced Middle East risk premium.

Claude’s Call

UP — The Nasdaq reclaims leadership today as the Iran deal removes a geopolitical overhang and Trump’s Apple-Intel chip announcement reignites semiconductor enthusiasm, but I’d fade strength into the close given Warsh’s hawkish lean hasn’t been fully digested and Monday could bring renewed rate anxiety.

Top Movers

BFLY (+52.4%) — $8.90 → $7.00 (AVOID — -21% downside risk) Thesis: Midjourney unveiled a medical imaging platform built on Butterfly’s Ultrasound-on-Chip technology, which is a legitimate commercial validation of their semiconductor platform in AI healthcare. However, this is a 52% single-day move on a $5.54-to-$8.90 stock with RSI at 84.6 — this is the definition of “buy the rumor, sell the news” territory. Zacks explicitly notes earnings estimate revisions don’t support further upside. Levels: No reliable resistance overhead after a move this extreme. Prior support around $5.50 (pre-announcement price).

HQ (+33.0%) — $32.00 → extreme caution warranted Thesis: Horizon Quantum is riding the quantum computing hype cycle hard — up 208% on the week with RSI at a mathematically impossible 146.7 (data anomaly, but directionally screaming overbought). Needham initiated with a Buy and $20 target on June 3rd — the stock has already blown past that by 60%. The quantum space is seeing genuine government funding tailwinds ($2B US push), but this is a momentum trade disconnected from fundamentals. Levels: Needham’s $20 PT is now far below. No technical framework applies after a 200%+ weekly move.

FCEL (+15.2%) — $24.04 → $28.00 (+16.5% upside) Thesis: FuelCell Energy is riding the AI data center power theme — 90% of their pipeline now targets AI/data center customers. An analyst just set a Street-high $30 PT despite an earnings miss, suggesting the market is looking through near-term losses to the structural demand story. The fuel cell sector is moving in tandem (BE +13.3%), giving this broad-based conviction. Levels: Street-high PT at $30 provides the upside ceiling. Support at $20.90 (pre-earnings level).

QS (+15.1%) — $8.04 → $9.50 (+18.2% upside) Thesis: Honda partnership on solid-state battery R&D is a genuine de-risking event — “multi-year plan” language and Honda COO’s direct endorsement give this more substance than typical EV battery press releases. RSI at 3.98 (deeply oversold coming into this move) suggests this is a bounce from extreme pessimism rather than a chase at highs. The low price makes it susceptible to momentum continuation. Levels: Prior resistance around $9.50-$10.00 zone. Support at $7.00 (recent lows pre-announcement).

BE (+13.3%) — $328.91 → $360.00 (+9.5% upside) Thesis: Bloom Energy’s $5B Brookfield AI infrastructure deal and $2.65B AEP offtake project are transformational — these are multi-gigawatt, 20-year contracts that fundamentally change the revenue visibility of this business. This isn’t sector sympathy; it’s company-specific mega-deal flow positioning BE as THE onsite power solution for AI factories. Levels: $360 near-term target based on deal-implied valuation uplift. Support at $290 (pre-deal announcement level).

KMX (+12.5%) — $53.66 → $58.00 (+8.1% upside) Thesis: CarMax beat Q1 estimates on revenue growth and cost control, with multiple analysts upgrading their outlook. The new CEO narrative is gaining traction, though Morningstar flagged weak strategic detail and margin compression on retail sales (sacrificing margin for volume). This is a classic “beat with caveats” — the initial dip was bought, suggesting the market is giving management the benefit of the doubt. Levels: Exit at $58 (pre-selloff highs). Support at $48 (Wednesday’s post-earnings trough).

ENTG (+12.5%) — $178.77 → $195.00 (+9.1% upside) Thesis: Entegris surged after Trump announced Apple agreed to manufacture chips with Intel in the US — a foundry validation that directly benefits semiconductor materials suppliers like ENTG. This is picks-and-shovels exposure to US chip manufacturing reshoring, a multi-year structural theme. However, BofA’s survey showing semis as “most crowded trade ever” is a yellow flag. Levels: $195 resistance zone (prior highs). Support at $159 (pre-Apple announcement level).

MTN (+11.1%) — $144.78 → $155.00 (+7.1% upside) Thesis: Activist investor Oasis Capital is weighing a proxy fight to force Vail Resorts to sell its mountain properties, with Cloudflare CEO Matthew Prince publicly expressing willingness to invest $500M in Park City alone. The company has already engaged takeover-defense bankers. This is a classic activist/M&A catalyst that creates a floor under the stock — the best day in six years confirms market enthusiasm for asset unlocking. Levels: Exit at $155 (6-month resistance). Support at $130 (52-week low bounce level).

LEU (+11.8%) — $191.39 → $210.00 (+9.7% upside) Thesis: Centrus Energy signed a HALEU fuel supply deal with Oklo for five Aurora reactors with 2029 deliveries — this is real contracted revenue in the nuclear fuel chain, not speculative reactor development. Zacks notes earnings estimate revisions suggest further strength, and nuclear is benefiting from bipartisan policy support and AI data center power demand. Levels: $210 prior resistance. Support at $171 (pre-deal level).

HIMS (+10.2%) — $35.47 → $39.00 (+10.0% upside) Thesis: Barclays raised its target to $39 on accelerating GLP-1/weight-loss momentum, with a July FDA peptide decision serving as the next binary catalyst. The Novo Nordisk partnership gives institutional validation. This is a rare growth story where consensus is moving higher into a known catalyst date. Levels: Barclays $39 PT as exit target. Support at $30 (breakout level from earlier this week).

Headlines to Watch

  • Kevin Warsh’s hawkish Fed presser — The new Fed Chair signaled another potential hike in 2026; this is the single biggest risk to the current rally and will keep a ceiling on duration-sensitive growth names.
  • Trump announces Apple-Intel US chip manufacturing deal — Validates Intel’s foundry ambitions and lifts the entire semiconductor materials/equipment supply chain (ENTG, ACMR, LRCX beneficiaries).
  • US-Iran peace deal signed — Oil prices falling and geopolitical risk premium compressing; benefits consumer discretionary and airlines (JBLU +9.7%) while pressuring energy names.
  • BofA survey: Semiconductors “most crowded trade” in history (80%) — This is the contrarian red flag that preceded the last two sector corrections; be selective in chip names.
  • Bloom Energy lands $5B Brookfield AI power deal — Confirms that AI power demand is moving from narrative to contracted revenue; fuel cells are becoming infrastructure, not speculation.
  • Oklo-Centrus HALEU fuel supply agreement — Nuclear fuel chain is transitioning from concept to commercial contracts; LEU is the direct beneficiary.
  • Oasis Capital eyes proxy fight at Vail Resorts — Activist M&A catalyst creates asymmetric upside with a defined floor; watch for formal 13D filing.

Claude’s Top Picks

QS (+15.1% today, +11.2% week) — $8.04 → $9.50 (+18.2% upside) Valuation: At ~$3.5B market cap pre-revenue, QS is expensive on traditional metrics but the Honda partnership legitimizes the technology in a way that peer Solid Power lacks — this narrows the discount to Toyota-backed solid-state programs. Upside: RSI at 3.98 entering this move means extreme oversold conditions with a genuine fundamental catalyst — this combination historically produces multi-day follow-through in speculative names. Risk: Pre-revenue company with ongoing cash burn; Honda “research agreement” is non-binding and could fizzle without production commitments.

LEU (+11.8% today, +20.6% week) — $191.39 → $210.00 (+9.7% upside) Valuation: Centrus trades at a premium to uranium miners but at a discount to nuclear reactor developers (OKLO, SMR) despite having actual contracted revenue and operational enrichment capabilities. Upside: Oklo deal for five reactors with 2029 deliveries creates visible future revenue; Zacks notes positive earnings revision momentum, and nuclear policy tailwinds are bipartisan and strengthening. Risk: HALEU production capacity remains limited and execution-dependent; any nuclear policy reversal or reactor project cancellation would hit sentiment hard.

HIMS (+10.2% today, +22.9% week) — $35.47 → $39.00 (+10.0% upside) Valuation: At ~5x forward revenue with 30%+ growth, HIMS trades at a discount to DTC health peers; Barclays’ $39 target implies the market hasn’t fully priced the GLP-1 revenue ramp. Upside: July FDA peptide decision is a defined catalyst with asymmetric payoff — if favorable, it removes the biggest regulatory overhang and opens a massive addressable market expansion. Risk: Adverse FDA ruling on compounded peptides would crater the GLP-1 thesis overnight; binary catalyst means position sizing matters.

MTN (+11.1% today, +6.2% week) — $144.78 → $155.00 (+7.1% upside) Valuation: Vail trades at a steep discount to historical EV/EBITDA (trough valuation) after a year of visitor softness — activist involvement signals the market is undervaluing the real estate/resort assets. Upside: Proxy fight creates a hard catalyst timeline; named potential buyers (including a billionaire CEO publicly stating willingness to invest) establish credible M&A interest and create a valuation floor. Risk: Proxy fight may fail or result in modest board changes rather than a sale; underlying fundamentals (softer visitation, pass sales pressure) haven’t inflected yet.

BE (+13.3% today, +32.2% week) — $328.91 → $360.00 (+9.5% upside) Valuation: At $328, Bloom is trading at a premium to historical range, but the $5B Brookfield deal and $2.65B AEP offtake fundamentally change the contracted revenue base — forward multiples need re-rating. Upside: Multi-gigawatt, 20-year contracts provide revenue visibility that no other fuel cell company can match; AI data center buildout is a secular multi-year spending cycle in early innings. Risk: Execution risk on deploying fuel cells at unprecedented scale; higher-for-longer rates increase the discount rate on long-duration contracted cash flows.

Avoid

BFLY (+52.4%) — RSI 84.6 after a 57% weekly gain on a partnership announcement (not revenue). Midjourney connection is exciting but speculative; Zacks explicitly says earnings revisions don’t support further upside. Classic “sell the news” setup after a parabolic move.

HQ (+33.0%) — Up 208% in one week with RSI at extreme levels. Already 60% above Needham’s $20 price target set just two weeks ago. Quantum computing stocks have a pattern of spectacular rallies followed by equally spectacular collapses. No fundamental framework justifies this price.

WOLF (+13.4%) — Despite the GE Aerospace alliance and Gen 5 SiC news, Wolfspeed has been in a structural decline (article notes steep fall this month) and today’s move is described as “bargain-hunting” — these dead-cat bounces in troubled companies typically fail. The company is pivoting away from EV (weakness) toward defense (unproven revenue), and the “most crowded trade” survey applies directly here.

WSB Sentiment Check

MSFT — WSB says: MIXED (55% bullish) Claude says: PARTIALLY AGREE — Microsoft is the steady hand in the AI infrastructure trade with Azure growth and Copilot monetization providing fundamental support, but at these valuations the risk/reward is symmetric rather than skewed bullish. The mixed sentiment is appropriate; this isn’t a high-conviction swing trade in either direction.

SPCX — WSB says: BEARISH (30% bullish) Claude says: AGREE — SPCX (the SPAC ETF) being bearishly discussed makes sense given the broader risk-off tone from Warsh’s comments and the fact that SPACs are the first casualty when liquidity expectations tighten. Higher-for-longer kills SPAC economics.

MU — WSB says: MIXED (55% bullish) Claude says: PARTIALLY AGREE — Micron benefits from AI memory demand (HBM cycle), but BofA’s “most crowded trade” survey is a direct warning for semis. The mixed read is fair — fundamentally strong but positioning is dangerously one-sided. Wait for a pullback rather than chasing.

SNDK — WSB says: BULLISH (80% bullish) Claude says: PARTIALLY AGREE — Memory/storage names benefit from the same AI infrastructure buildout driving the broader semi rally, and SanDisk (Western Digital’s consumer brand) has a cleaner story post-split. The 80% bullish consensus is a slight contrarian flag, but the structural demand story is real.

AMD — WSB says: BULLISH (80% bullish) Claude says: AGREE — AMD continues to gain AI accelerator share with MI300X momentum, and the Apple-Intel news indirectly validates x86 ecosystem investments. The 80% bullish read is justified by fundamental execution, though I’d note that 80% consensus on WSB often marks a local top. Buy dips, don’t chase.